Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jun 11.
Published in final edited form as: J Adolesc. 2023 Feb 22;95(4):834–843. doi: 10.1002/jad.12157

The effect of family support on self-reported adherence to ART among adolescents perinatally infected with HIV in Uganda: A mediation analysis

Proscovia Nabunya 1, Kizito Samuel 1, Fred M Ssewamala 1
PMCID: PMC10257769  NIHMSID: NIHMS1877167  PMID: 36810778

Abstract

Introduction:

This study examined the mechanisms through which family support affects self-reported adherence to antiretroviral therapy among adolescents perinatally infected with HIV in Uganda.

Methods:

Longitudinal data from 702 adolescent boys and girls (10–16 years) were analyzed. Structural equation models were conducted to assess the direct, indirect, and total effects of family support on adherence.

Results:

Results showed a significant indirect effect of family support on adherence (β = .112, 95% confidence interval [CI]: 0.052–0.173, p < .001). Specific indirect effects of family support through saving attitudes (β = .058, 95% CI: 0.008–0.108, p = .024), and communication with the guardian (β = .056, 95% CI: 0.012–0.100), p = .013), as well as the total effect of family support on adherence (β = .146 (95% CI: 0.032–0.259, p = .012), were statistically significant. Mediation contributed 76.7% of the total effects.

Conclusion:

Findings support strategies to help promote family support and strengthen open communication between adolescents living with HIV and their caregivers.

Keywords: adolescents, child-caregiver communication, family support, HIV, self-reported adherence, social support

1 |. INTRODUCTION

An estimated 1.7 million children under < 15 years are living with HIV globally, the majority of these live in sub-Saharan Africa (SSA) (UNAIDS, 2021). Advances in antiretroviral therapy (ART) over the last decade have greatly improved health outcomes, disease progression and life expectancy for people living with HIV (Burger et al., 2022; Forsythe et al., 2019). However, these benefits depend greatly on an individual’s ability to adhere to prescribed medication regimens (Peltzer & Pengpid, 2013). While the World Health Organization established guidelines recommending ART to be initiated for anyone living with HIV regardless of CD4 count (World Health Organization, 2015), ART coverage for children is still lower than that of adults in developing countries, especially in SSA (Ahmed & Lemma, 2019).

HIV medication adherence is complicated for adolescents in low resource settings (Enane et al., 2018; Mark et al., 2017). Globally, only 40% of adolescents on ART had suppressed viral load compared to 67% of adults (UNAIDS, 2021). Adolescents living with HIV (ALHIV) have to confront the psychosocial issues, maintain adherence to drugs and learn to negotiate sexual relationships while undergoing rapid physical and psychological development (Enane et al., 2018; Hazra et al., 2010). Factors associated with suboptimal adherence to ART among ALHIV in low-resource settings include developmental characteristics, social and economic factors such as poverty, stigma and discrimination, burdensome ART regimens, lack of social support, serostatus nondisclosure, limited adherence clinical knowledge, clinic environments, including the lack of adolescent-friendly services to facilitate access to the limited available health care services (Ammon et al., 2018; Hudelson & Cluver, 2015). Yet, suboptimal adherence is associated with increased risk of viral progression, HIV transmission and viral resistance (Ajose et al., 2012; Bangsberg et al., 2001; San-Andres et al., 2003). As such, promoting adherence remains an important care element for children and ALHIV.

1.1 |. Family support and medication adherence

Social support, especially from family members, has been shown to influence adherence to treatment protocols (DiMatteo, 2004a; Shahin et al., 2021; Williams et al., 2006). Social support can be categorized into emotional (e.g., love, trust, care, and empathy), instrumental (e.g., provision of tangible or practical support), informational (e.g., provision of advice) and appraisal support (e.g., self-esteem, confidence building) (Cohen & Wills, 1985; House, 1981; Langford et al., 1997). Each type of support provides unique resources to mitigates stressors (Cohen & McKay, 1984; House, 1981). For example, while emotional support may alleviate stress through the provision of psychological resources, including communication, listening and empathy, instrumental support provides tangible resources and assistance that directly alleviate stressors.

In HIV-related studies, perceived emotional support from family members (Poudel et al., 2015), family cohesion and social support from caregivers (Damulira et al., 2019), as well as caregiver characteristics such as having an adult other than the biological parent as the primary caregiver, caregiver education level (Williams et al., 2006), and caregiver’s knowledge about the importance of treatment and adherence (Arage et al., 2014; Biadgilign et al., 2009), were all associated with improved adherence. Family cohesion and positive child-caregiver communication have also been associated with adherence self-efficacy (Nabunya et al., 2020). Nonadherence was related to worse parent–child communication, higher levels of caregiver stress, lower caregiver quality of life and worse caregiver cognitive functioning (Mellins et al., 2004). Instrumental support—the focus of this study, involves tangible, or practical forms of support, such as task assistance, funds, and direct interventions (Cohen & McKay, 1984; French et al., 2018; Friedman & King, 1994). Instrumental support has been documented as having the strongest effect on adherence compared to other forms of support (DiMatteo, 2004b). Family members promote treatment adherence by facilitating access to HIV care through the provision of financial support, having accurate knowledge about medication and adherence, providing motivation to adhere to treatment, directly reminding or helping the patient to take medication, meal preparation and facilitating medical transportation to health clinics (Fredriksen-Goldsen et al., 2011).

While several studies have investigated the role of family support, the mechanisms through which family support impacts ART adherence is rarely investigated. This study examines the mediators of the effect of family support, specifically, instrumental support, on self-reported ART adherence among ALHIV in Uganda. Comprehensive psychosocial services for individuals living with HIV in Uganda, including access to comprehensive counseling services and home-based care services are very low and some have been phased out completely, leaving families with the primary responsibility of providing care and support with no or minimal government support. As such, understanding the mechanisms through which specific types of support from family members affect adherence, is essential in promoting and facilitating treatment adherence, especially among children and adolescents, whose adherence needs depend largely on their caregivers.

2 |. METHODS

2.1 |. Sample and setting

Data from the Suubi+Adherence study (2012–2018), a randomized experimental study were analyzed. The study examined a family-based economic empowerment intervention aimed at improving adherence to medication for ALHIV in rural Uganda (Ssewamala et al., 2019). A total of 702 ALHIV between ages 10–16 years were enrolled in the study. Adolescents were eligible to participate if they were HIV-positive as confirmed by medical records, and disclosed to, prescribed antiretroviral therapy, lived within a family, not an institution, and enrolled in one of the 39 health clinics in the study region. Participants were recruited from health clinics located in Rakai, Masaka, Lwengo, Lyantonde, Bukomasimbi, and Kalungu Districts—a region with high prevalence for HIV, compared to the national average (Uganda AIDS Commission, 2021). Details on participant recruitment and the intervention are provided in the study protocol (Ssewamala et al., 2019) and elsewhere (Ssewamala et al., 2020; Tozan et al., 2021).

2.2 |. Data collection and measures

Data was collected using a 90-min interviewer-administered assessment battery by trained research assistants. Assessment measures and all study related materials were translated into Luganda—the local language and back translated into English to ensure consistency. All measures have been tested in our previous studies in the study region (Nyoni et al., 2019; Osuji et al., 2018; Ssewamala & Ismayilova, 2009). A description of measures utilized in this analysis is provide below.

2.2.1 |. Outcome variable

Self-reported adherence was measured using six items: (1) When was the last time you missed any of your medication? (1 = “Never missed medication” to 6 = “More than 3 months ago”); (2) In the last 30 days, on how many days did you miss at least one dose of any of your HIV medicine? (3) In the last 30 days, how often did you take your HIV medicine in the way you were supposed to? (1 = “Never” to 5 = “Always”); (4) In general, over the past 6 months, how often did you miss taking your medication? (1 = “I have not taken any medication over the past 6 months” to 6 = “I never miss taking any of my medicines/I take my medicines all the time”); 5) How hard is it for you to take your HIV medicine in the way you are supposed to? (1 = “Extremely hard” to 5 = “Not hard at all”); and (6) How often do you argue with the person helping you to take your medicine? (1 = “Never” to 5 = “Always”). A latent construct for adherence was generated using these six questions.

2.2.2 |. Independent variable

Family support was measured by three items assessing instrumental support: (1) Who helps you take your HIV medicines or helps you remember to take them (such as mother, father, friend, nurse/medical professional, etc.)? (2) How often does this person help you when it comes to taking your medication? (5 = always to 1 = never); and (3) How likely is it that this person would know when you miss your medication? (4 = very likely to 1 = very unlikely). Responses from items 2 and 3 were summed and the total score was dichotomized into 0 = total score of 5 or less (less responsible), and 1 = total score of more than 5 (more responsible). A latent construct for family support was generated using items 2 and 3.

2.2.3 |. Mediator variables

Mediator variables included caregiver support, caregiver communication, food security, having personal savings, savings attitudes, and school enrollment. Caregiver support was measured using 18-items related to emotional support (e.g., acceptance and warmth). Responses were rated on a 5-point scale (with 1 = Never and 5 = Always). Summary scores were generated, with higher scores indicating higher levels of perceived caregiver support. Communication with the parent/guardian was assessed by asking participants how often they discuss specific topics (such as HIV/AIDS, puberty, education and future planning, among others) with their caregivers, on a 5-point scale (with 1 = Never and 5 = Always). Food security was assessed by a composite score generated using three items: (1) whether the participant had breakfast on the interview day (1 = yes, 0 = no), (2) how many times the participant ate fish or meat in the week preceding the interview (0 = once or none, 1 = twice or more), and the number of meals that the participant has per day (0 = one or none, 1 = two or more meals). Personal savings were assessed by asking participants whether they have any money saved anywhere (yes/no). Savings attitudes were assessed by asking participants to state the importance of saving for six goals related to family assistance, family business, education, vocational training, buying an animal for income generation or moving into one’s own house. Responses were rated on a 5-point scale (with 1 = Not important at all and 5 = Extremely important). For school enrollment, participants were asked whether they were currently enrolled in school at the time of baseline assessments (yes/no). Participants’ household size, gender and pill burden were included in the model as control variables.

2.3 |. Analysis procedures

Descriptive analyses were conducted on the sample and household characteristics, self-reported adherence and family support factors using STATA 17. Mplus version 8 was used to fit structural equation models that assessed the direct, indirect, and total effects of family support on self-reported ART adherence. The mediators included in the models were saving attitudes, having savings, being enrolled in school, food security, caregiver support, and communication with the caregiver. We controlled for participants’ gender, household size, and pill burden. For all the analyses, cluster adjusted robust standard errors were reported. In the results tables, nonstandardized coefficients, (B), were reported, in addition to standardized coefficients, (β), and the corresponding 95% confidence intervals (CI). p values that were .05 or less were considered significant. A χ2 goodness of fit value was calculated; however, it was significant. Therefore, model fitness was estimated by considering a Root Mean Square Error of Approximation (RMSEA) of less than 0.06, Comparative Fit Index (CFI) of more than 0.92, and the Standardized Root Mean Square Residual (SRMR) of less than 0.08.

3 |. RESULTS

3.1 |. Sample characteristics

Baseline sample characteristics are presented in Table 1. Fifty-six percent (56%) of participants were females. The average age of participants was 12.4 years. More than one-third of participants (37.8%) were single orphans—meaning they had one surviving biological parent and 35% had both their biological parents living (non-orphans). Majority of participants (87.3%) were currently enrolled in school (at baseline assessment). In terms of household characteristics, almost half of the participants (47%) reported a surviving biological parent as their primary caregiver and 29.4% reported their grandparent(s). Participants lived in households with an average of 5.7 individuals, with 2.4 children under 18 years. Only 29% of participants reported having personal savings. Most participants (77.2%) were taking more than one type of HIV medication daily. In addition, 91% of adolescent reported never to rarely argue with the person helping them to take their medication.

TABLE 1.

Sample characteristics (N =702).

Variable n (%)

Gender
 Female 396 (56.4)
 Male 306 (43.6)
Age (Mean ± SD) 12.42 ± 1.98
Orphanhood status
 Double orphan 192 (27.4)
 Single orphan 264 (37.6)
 Non-orphan 246 (35)
School enrollment
 Currently enrolled 613 (87.3)
 Not enrolled 89 (12.7)
Household characteristics
 Primary caregiver
  Biological parent 331 (47.1)
  Grandparents 206 (29.4)
Other relative (siblings, aunt, uncle, other) 165 (23.5)
Mean number of people in HH ± SD (min/max: 2–18) 5.7 ± 2.6
Mean number of children in HH ± SD (min/max: 1–14) 2.4 ± 1.9
Mean food security score ± SD (min/max: 0–7) 3.9 ± 1.6
Availability of savings (yes) 205 (29.2)
Mean saving attitudes score ± SD (min/max: 13–30) 26.5 ± 3.2
How many different HIV medicines do you take?
 One 160 (22.8)
 More than one 542 (77.2)

3.2 |. Family support and self-reported adherence

Adolescents’ self-reported adherence to medication and family support is presented in Table 2. Adolescents reported high levels of adherence to medication, with 70% reporting no missed medicines at all, 72% had not missed any of their medication in the last 6 months, and about 90% reported usually or always taking their medication as prescribed. The majority (85.6%) reported no difficulty (not hard to not hard at all) taking their medication.

TABLE 2.

Self-reported adherence and family-level factors.

Variables n (%)

Self-reported adherence
 When was the last time you missed any of your medication?
  Never missed 494 (70.4)
  Within the past week to More than 3 months ago 208 (29.6)
 How often did you take your medication in a prescribed manner in the last 30 days?
  Usually to always 630 (89.7)
  Sometimes to Never 72 (10.3)
 How often did you miss taking your medication in the past 6 months?
  Never missed 506 (72.1)
  A little bit to have not taken any medication 196 (27.9)
 How hard is it for you to take your HIV medicine as prescribed?
  Extremely hard to hard 101 (14.4)
  Not hard to not hard at all 601 (85.6)
 How often do you argue with the person helping you take medication?
  Never to rarely 640 (91.2)
  Sometimes to always 62 (8.8)
Family support
 Who helps you take or remember taking you medication?
  Biological parent 292 (41.6)
  Grandparent 181 (25.8)
  Other person (extended family member, teachers, nurse) 130 (18.5)
  No one 99 (14.1)
 How often does this person help you to take your medication?
  Never to half the time 140 (19.9)
  Most of the time to always 562 (80.1)
 How likely would this person know when you miss taking your medication?
  Somewhat likely to very likely 585 (83.3)
  Somewhat unlikely to very unlikely 117 (16.7)
 Caregiver support (Mean, SD)
  Frequency of communication with caregiver (min/max: 10–55) 24.8 ± 8.0

Regarding family support, majority of adolescents (86%) reported receiving instrumental support. Specifically, 41.6% of adolescents reported that their biological parent helped them take or remember to take their medication and 14% reported no support at all. For those who received support, 80% reported that support was received always or most of the time, and 83.4% reported that the individual supporting them would likely or very likely know if the adolescent missed taking their medication.

3.3 |. Mediation analysis

Table 3 presents results from the structural equation modeling analysis for the mediators of the effect of family support on self-reported adherence. The SEM results showed that there was a significant indirect effect of family support on ART adherence (B = 0.008, β = .112 [95% CI: 0.052–0.173], p < .001). Particularly, the specific indirect effects of family support through saving attitudes (B = 0.004, β = .058 [95% CI: 0.008–0.108], p = .024), and communication with the guardian (B = 0.004, β = .056 [95% CI: 0.012–0.100], p = .013) were statistically significant. Also, the total effect of family support on ART adherence was statistically significant (B = 0.011, β = .146 [95% CI: 0.032–0.259], p = .012). However, the direct effect was not significant (Figure 1).

TABLE 3.

Mediation analysis.

Variable B β (95% CI) p Value

Family support on mediators
 Saving attitudes 0.189 .391 (0.321–0.461) <.001
 Caregiver support 0.035 .154 (0.069–0.239) <.001
 Having savings −0.046 −.109 (−0.180–−0.039) .002
 Enrolled in school −0.002 −.012 (−0.087–0.063) .751
 Food security −0.001 −.016 (−0.077–0.045) .608
 Communication with the guardian 0.197 .351 (0.271–0.431) <.001
Mediators on ART adherence
 Saving attitudes 0.023 .148 (0.022–0.275) .021
 Caregiver support −0.002 −.006 (−0.140–0.128) .925
 Having savings −0.002 −.009 (−0.119–0.101) .872
 Enrolled in school 0.022 .053 (−0.010–0.117) .099
 Food security 0.095 .071 (−0.013–0.156) .098
 Communication with the guardian 0.021 .159 (0.047–0.271) .005
Specific indirect effects
 Saving attitudes 0.004 .058 (0.008–0.108) .024
 Caregiver support <0.001 −.001 (−0.022–0.020) .925
 Having savings <0.001 .001 (−0.011–0.013) .873
 Enrolled in school <0.001 −.001 (−0.005–0.003) .755
 Food security <0.001 −.001 (−0.006–0.004) .653
 Communication with the guardian 0.004 .056 (0.012–0.100) .013
Effects
 Direct effect 0.003 .034 (−0.093–0.160) .602
 Total indirect effect 0.008 .112 (0.052–0.173) <.001
 Total effect 0.011 .146 (0.032–0.259) .012
 Effect mediated 76.7%
Model fitness
R2 β = .072, p = .016
χ2 χ2 (81) = 131.6, p <.001
 CFI 0.939
 RMSEA 0.032
 SRMR 0.037

Note: Bold values represent statistically significant associations.

Abbreviations: CFI, Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation; SRMR, Standardized Root Mean Square Residual.

FIGURE 1.

FIGURE 1

Structural equation model showing the effect of family support on self-reported ART adherence among ALHIV in Southern Uganda. We reported standardized coefficients. Significant associations are illustrated with bold arrows. ALHIV, adolescents living with HIV; ART, antiretroviral therapy.

In the model, mediation contributed 76.7% of the total effects. Controlling for participants’ characteristics, we were able to explain only 7.2% of the variance (R2 = .072, p = .016). The model fitness parameters included CFI = 0.939, RMSEA = 0.032, and SRMR = 0.037.

4 |. DISCUSSION

This paper examined the effect of family support on self-reported adherence to medication among ALHIV in Uganda. First, study findings indicate high levels of self-reported adherence to ART. We find that 70% of the sample reported that they had never missed any medication and about 90% reported taking their medication in a prescribed way. This finding is consistent with previous studies in the region that have documented self-reported adherence among ALHIV (Dachew et al., 2014; Vreeman et al., 2018). It is possible that once adolescents are disclosed to and understand the importance of taking their medication, they are more likely to adhere to medication without conflicting with their caregivers. Indeed, studies have documented improved adherence as one of the benefits associated with HIV disclosure among children and adolescents (Cluver et al., 2015; Krauss et al., 2016; Nichols et al., 2017). Alternatively, it could be that given the young age of adolescents in the sample, it is easier for them to take their medication as prescribed. Young children also tend to report higher levels of adherence compared to older adolescents. However, adherence tend to decline as children grow older potentially due to the transfer of responsibility from caregivers to adolescents themselves (Adejumo et al., 2015; Mellins et al., 2004).

Second, majority of participants (86%) reported receiving family support in the form of instrumental support from family members. Given the young age of study participants, it is not surprising that family members are actively involved to make sure that adolescents adhere to their treatment, specifically, by helping them or reminding them to take their medication (Denison et al., 2015; Gichane et al., 2018). However, while the positive role of instrumental support on ART adherence has been documented (Fredriksen-Goldsen et al., 2011), its direct effect on adherence was not significant in our study—signifying that this form of support alone may not be enough to promote adherence. For adolescents who did not report family support (14%), it could be that they are fully responsible for their own treatment adherence needs.

Third, regarding potential pathways, we find that family support impacted self-reported adherence through both communication with the caregiver and positive savings attitudes. Specifically, family support may improve child-caregiver communication, which in turn, was associated with self-reported adherence. Studies have documented that children’s knowledge of the purpose of taking medication, as well as how to take it correctly depends on their caregivers and require open communication with the child (Bikaako-Kajura et al., 2006; Stein et al., 2019; Taddeo et al., 2008). It is possible that caregivers who are actively involved in their children’s treatment are more likely to engage in open communication, regarding HIV illness in general, as well as the importance of adhering to medication. Moreover, given that communication among caregivers of children living with HIV is still low (Kajubi et al., 2014, 2016), this finding support other studies that have documented the importance of effective parent-child communication in fostering pediatric adherence to treatment (DiMatteo, 2004b; Kajubi et al., 2014, 2016; Mellins et al., 2004; Stein et al., 2019).

For savings attitudes, it is possible that family support improves saving attitudes around the importance of saving to take care of one’s family, including their medical expenses. Specifically, positive savings attitudes may act as a proxy for savings behaviors. For example, those with positive savings attitudes may be more likely to save—which may help to meet their medical needs, including affording transportation to get to their clinic appointments and also purchase food to facilitate medication intake. While self-reported savings was not a significant pathway in our analyses, in a separate analysis that utilized actual saving records from financial institution, participants with savings reported better ART adherence (Brathwaite et al., 2022). This finding aligns with previous studies related to financial savings, possession of household economic assets, and their association with greater odds of self-reported adherence (Bermudez et al., 2016) and viral suppression among ALHIV (Bermudez et al., 2018).

A few limitations are worth noting. We report self-reported adherence which may be influenced by social desirability. Also, we analyzed cross-sectional data which does not allow us to examine the impact of family support over time.

Despite these limitations, study findings contribute to the limited literature that has investigated the pathways through which family support affects ART treatment adherence among ALHIV. Our study findings indicate that family support (i.e., provision of instrumental support), specifically through child-caregiver communication and positive attitudes towards financial savings is crucial in facilitating and promoting ART adherence among ALHIV. Programs that work to promote treatment outcomes, especially for children and ALHIV, should incorporate strategies that help improve overall family support and open communication with children on issues regarding HIV, as well as medication and adherence, as they try to navigate the transition through adolescence and into young adulthood.

ACKNOWLEDGMENTS

We are grateful to the staff and the volunteer team at the International Center for Child Health and Development (ICHAD) in Uganda Field Office for monitoring the study implementation process. Our special thanks go to all children and their caregiving families who agreed to participate in the study. This work was supported by the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD, Grant # R01HD074949, PI: Fred M. Ssewamala). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of NICHD or NIH.

Footnotes

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

ETHICS STATEMENT

Participation in the study was voluntary. Informed consent and assent were obtained from caregivers and adolescents, respectively, before study participation. The study received Institutional Review Board (IRB) approval from Columbia University (AAAK3852), the Uganda National Council for Science and Technology (UNCST, SS 2969), and Makerere University School of Public Health Higher Degrees, Research and Ethics Committee (210). The study is registered on ClinicalTrials.gov Identifier: NCT01790373.

DATA AVAILABILITY STATEMENT

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

REFERENCES

  1. Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, & Taiwo BO (2015). Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: A narrative review. Journal of the International AIDS Society, 18(1), 20049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed I & Lemma S (2019). Mortality among pediatric patients on HIV treatment in sub-Saharan African countries: A systematic review and meta-analysis. BMC Public Health, 19(1), 149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ajose O, Mookerjee S, Mills EJ, Boulle A, & Ford N (2012). Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: A systematic review and meta-analysis. AIDS, 26(8), 929–938. [DOI] [PubMed] [Google Scholar]
  4. Ammon N, Mason S, & Corkery JM (2018). Factors impacting antiretroviral therapy adherence among human immunodeficiency virus–positive adolescents in sub-Saharan Africa: A systematic review. Public Health, 157, 20–31. [DOI] [PubMed] [Google Scholar]
  5. Arage G, Tessema GA, & Kassa H (2014). Adherence to antiretroviral therapy and its associated factors among children at south wollo zone hospitals, northeast Ethiopia: A cross-sectional study. BMC Public Health, 14(1), 365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, & Moss A (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15(9), 1181–1183. [DOI] [PubMed] [Google Scholar]
  7. Bermudez LG, Jennings L, Ssewamala FM, Nabunya P, Mellins C, & McKay M (2016). Equity in adherence to antiretroviral therapy among economically vulnerable adolescents living with HIV in Uganda. AIDS Care, 28(Supp 2), 83–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bermudez LG, Ssewamala FM, Neilands TB, Lu L, Jennings L, Nakigozi G, Mellins CA, McKay M, & Mukasa M (2018). Does economic strengthening improve viral suppression among adolescents living with HIV? Results from a cluster randomized trial in Uganda. AIDS and Behavior, 22(11), 3763–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Biadgilign S, Deribew A, Amberbir A, & Deribe K (2009). Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA-J: Journal of Social Aspects of HIV/AIDS, 6(4), 148–154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, Malamba S, & Bunnell R (2006). Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS and Behavior, 10(1), 85–93. [DOI] [PubMed] [Google Scholar]
  11. Brathwaite R, Ssewamala FM, Mutumba M, Neilands TB, Byansi W, Namuwonge F, Damulira C, Nabunya P, Nakigozi G, Makumbi F, Mellins CA, McKay MM, & Team AF (2022). The long-term (5-year) impact of a family economic empowerment intervention on adolescents living with HIV in Uganda: Analysis of longitudinal data from a cluster randomized controlled trial from the Suubi+Adherence study (2012–2018). AIDS and Behavior, 26(10), 3337–3344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burger C, Burger R, & van Doorslaer E (2022). The health impact of free access to antiretroviral therapy in South Africa. Social Science & Medicine, 299, 114832. [DOI] [PubMed] [Google Scholar]
  13. Cluver LD, Hodes RJ, Toska E, Kidia KK, Orkin FM, Sherr L, & Meinck F (2015). ‘HIV is like a tsotsi. ARVs are your guns’: Associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa. AIDS, 29, S57–S65. [DOI] [PubMed] [Google Scholar]
  14. Cohen S & McKay G (1984). Social support, stress and the buffering hypothesis: A theoretical analysis. Handbook of Psychology and Health, 4, 253–267. [Google Scholar]
  15. Cohen S & Wills TA (1985). Stress, social support, and the buffering hypothesis. Psychological Bulletin, 98, 310–357. [PubMed] [Google Scholar]
  16. Dachew BA, Tesfahunegn TB, & Birhanu AM (2014). Adherence to highly active antiretroviral therapy and associated factors among children at the university of gondar hospital and gondar poly clinic, northwest Ethiopia: A cross-sectional institutional based study. BMC Public Health, 14, 875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Damulira C, Mukasa MN, Byansi W, Nabunya P, Kivumbi A, Namatovu P, Namuwonge F, Dvalishvili D, Sensoy Bahar O, & Ssewamala FM (2019). Examining the relationship of social support and family cohesion on ART adherence among HIV-positive adolescents in Southern Uganda: Baseline findings. Vulnerable children and youth studies, 14(2), 181–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Denison JA, Banda H, Dennis AC, Packer C, Nyambe N, Stalter RM, Mwansa JK, Katayamoyo P, & McCarraher DR (2015). “The sky is the limit”: Adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers. Journal of the International AIDS Society, 18(1), 19358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. DiMatteo MR (2004a). Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology, 23(2), 207. [DOI] [PubMed] [Google Scholar]
  20. DiMatteo MR (2004b). The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Education and Counseling, 55(3), 339–344. [DOI] [PubMed] [Google Scholar]
  21. Enane LA, Vreeman RC, & Foster C (2018). Retention and adherence: Global challenges for the long-term care of adolescents and young adults living with HIV. Current Opinion in HIV and AIDS, 13(3), 212–219. [DOI] [PubMed] [Google Scholar]
  22. Forsythe SS, McGreevey W, Whiteside A, Shah M, Cohen J, Hecht R, Bollinger LA, & Kinghorn A (2019). Twenty years of antiretroviral therapy for people living with HIV: Global costs, health achievements, economic benefits. Health Affairs, 38(7), 1163–72. [DOI] [PubMed] [Google Scholar]
  23. Fredriksen-Goldsen KI, Shiu CS, Starks H, Chen WT, Simoni J, Kim HJ, Pearson C, Zhao H, & Zhang F (2011). “You must take the medications for you and for me”: Family caregivers promoting HIV medication adherence in China. AIDS Patient Care and STDs, 25(12), 735–741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. French KA, Dumani S, Allen TD, & Shockley KM (2018). A meta-analysis of work-family conflict and social support. Psychological Bulletin, 144, 284–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Friedman MM, & King KB (1994). The relationship of emotional and tangible support to psychological well-being among older women with heart failure. Research in Nursing & Health, 17, 433–440. [DOI] [PubMed] [Google Scholar]
  26. Gichane MW, Sullivan KA, Shayo AM, Mmbaga BT, O’ Donnell K, Cunningham CK, & Dow DE (2018). Caregiver role in HIV medication adherence among HIV-infected orphans in Tanzania. AIDS Care, 30(6), 701–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hazra R, Siberry GK, & Mofenson LM (2010). Growing up with HIV: Children, adolescents, and young adults with perinatally acquired HIV infection. Annual Review of Medicine, 61, 169–85. [DOI] [PubMed] [Google Scholar]
  28. House JS (1981). Work stress, and social support. Addison-Wesley. Reading, MA. [Google Scholar]
  29. Hudelson C, & Cluver L (2015. Jul 3). Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low-and middle-income countries: A systematic review. AIDS Care, 27(7), 805–816. [DOI] [PubMed] [Google Scholar]
  30. Kajubi P, Whyte S, Muhumuza S, Kyaddondo D, & Katahoire AR (2014). Communication between HIV-infected children and their caregivers about HIV medicines: A cross-sectional study in Jinja district, Uganda. Journal of the International AIDS Society, 17(1), 19012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kajubi P, Whyte SR, Kyaddondo D, & Katahoire AR (2016). Tensions in communication between children on antiretroviral therapy and their caregivers: A qualitative study in jinja district, Uganda. PLoS One, 11(1), e0147119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Krauss BJ, Letteney S, & Okoro CN (2016). Why tell children: A synthesis of the global literature on reasons for disclosing or not disclosing an HIV diagnosis to children 12 and under. Frontiers in Public Health, 4, 181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Langford CPH, Bowsher J, Maloney JP, & Lillis PP (1997). Social support: A conceptual analysis. Journal of Advanced Nursing, 25(1), 95–100. [DOI] [PubMed] [Google Scholar]
  34. Mark D, Armstrong A, Andrade C, Penazzato M, Hatane L, Taing L, Runciman T, & Ferguson J (2017). HIV treatment and care services for adolescents: A situational analysis of 218 facilities in 23 sub-Saharan African countries. Journal of the International AIDS Society, 20, 21591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mellins CA, Brackis-Cott E, Dolezal C, & Abrams EJ (2004). The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal, 23(11), 1035–1041. [DOI] [PubMed] [Google Scholar]
  36. Nabunya P, Bahar OS, Chen B, Dvalishvili D, Damulira C, & Ssewamala FM (2020). The role of family factors in antiretroviral therapy (ART) adherence self-efficacy among HIV-infected adolescents in Southern Uganda. BMC Public Health, 20(1), 340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nichols J, Steinmetz A, & Paintsil E (2017). Impact of HIV-status disclosure on adherence to antiretroviral therapy among HIV-infected children in resource-limited settings: A systematic review. AIDS and Behavior, 21(1), 59–69. [DOI] [PubMed] [Google Scholar]
  38. Nyoni T, Nabunya P, & Ssewamala FM (2019). Perceived social support and psychological wellbeing of children orphaned by HIV/AIDS in Southwestern Uganda. Vulnerable Children and Youth Studies, 14(4), 351–363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Osuji HL, Nabunya P, Byansi W, Parchment TM, Ssewamala F, McKay MM, & Huang KY (2018). Social support and school outcomes of adolescents orphaned and made vulnerable by HIV/AIDS living in Southwestern Uganda. Vulnerable children and youth studies, 13(3), 228–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Peltzer K, & Pengpid S (2013). Socioeconomic factors in adherence to HIV therapy in low-and middle-income countries. Journal of Health, Population, and Nutrition, 31(2), 150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Poudel KC, Buchanan DR, Amiya RM, & Poudel-Tandukar K (2015). Perceived family support and antiretroviral adherence in HIV-positive individuals: Results from a community-based positive living with HIV study. International Quarterly of Community Health Education, 36(1), 71–91. [DOI] [PubMed] [Google Scholar]
  42. San-Andres FJ, Rubio R, Castilla J, Pulido F, Palao G, Pedro I, Costa JR, & Palacio A (2003). Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989–1997. Clinical Infectious Diseases, 36(9), 1177–85. [DOI] [PubMed] [Google Scholar]
  43. Shahin W, Kennedy GA, & Stupans I (2021). The association between social support and medication adherence in patients with hypertension: A systematic review. Pharmacy Practice, 19(2), 2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ssewamala FM, Byansi W, Bahar OS, Nabunya P, Neilands TB, Mellins C, McKay M, Namuwonge F, Mukasa M, Makumbi FE, & Nakigozi G (2019). Suubi+adherence study protocol: A family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents. Contemporary Clinical Trials Communications, 16, 100463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ssewamala FM, Dvalishvili D, Mellins CA, Geng EH, Makumbi F, Neilands TB, McKay M, Damulira C, Nabunya P, Sensoy Bahar O, Nakigozi G, Kigozi G, Byansi W, Mukasa M, & Namuwonge F (2020). The long-term effects of a family based economic empowerment intervention (Suubi+Adherence) on suppression of HIV viral loads among adolescents living with HIV in Southern Uganda: Findings from 5-year cluster randomized trial. PLoS One, 15(2), e0228370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ssewamala FM, & Ismayilova L (2009). Integrating children’s savings accounts in the care and support of orphaned adolescents in rural Uganda. Social Service Review, 83(3), 453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stein A, Dalton L, Rapa E, Bluebond-Langner M, Hanington L, Stein KF, Ziebland S, Rochat T, Harrop E, Kelly B, Bland R, Betancourt T, D’Souza C, Fazel M, Hochhauser D, Kolucki B, Lowney AC, Netsi E, Richter L, & Yousafzai A (2019). Communication with children and adolescents about the diagnosis of their own life-threatening condition. The Lancet, 393(10176), 1150–63. [DOI] [PubMed] [Google Scholar]
  48. Taddeo D, Egedy M, & Frappier JY (2008). Adherence to treatment in adolescents. Paediatrics & Child Health, 13(1), 19–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tozan Y, Capasso A, Sun S, Neilands TB, Damulira C, Namuwonge F, Nakigozi G, Mwebembezi A, Mukasa B, Sensoy Bahar O, Nabunya P, Mellins CA, McKay MM, & Ssewamala FM (2021). The efficacy and cost-effectiveness of a family-based economic empowerment intervention (Suubi+Adherence) on suppression of HIV viral loads among adolescents living with HIV: Results from a cluster randomized controlled trial in Southern Uganda. Journal of the International AIDS Society, 24(6), e25752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Uganda AIDS Commission. (2021). Fact sheet: Facts on HIV and AIDS in Uganda. 2021. https://uac.go.ug/media/attachments/2021/09/13/final-2021-hiv-aids-factsheet.pdf
  51. UNAIDS. (2021). UNAIDS data. https://www.unaids.org/en/resources/documents/2021/2021_unaids_data
  52. Vreeman RC, Ayaya SO, Musick BS, Yiannoutsos CT, Cohen CR, Nash D, Wabwire D, Wools-Kaloustian K, & Wiehe SE (2018). Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa. PLoS One, 13(2), e0191848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA, Farley J, & Malee K (2006). Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics, 118(6), e1745–e1757. [DOI] [PubMed] [Google Scholar]
  54. World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

RESOURCES